Alex Polotsky
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 16 | 2024 | 109 | 3.320 |
Why?
| | Obesity | 31 | 2026 | 3131 | 3.270 |
Why?
| | Follicle Stimulating Hormone | 14 | 2023 | 265 | 2.900 |
Why?
| | Infertility, Female | 12 | 2026 | 124 | 2.880 |
Why?
| | Live Birth | 12 | 2024 | 81 | 2.870 |
Why?
| | Oocytes | 8 | 2026 | 186 | 2.710 |
Why?
| | Embryo Transfer | 8 | 2024 | 45 | 2.340 |
Why?
| | Luteinizing Hormone | 16 | 2021 | 206 | 2.300 |
Why?
| | Pregnancy Rate | 12 | 2024 | 83 | 2.070 |
Why?
| | Menopause | 7 | 2014 | 328 | 1.830 |
Why?
| | Gonadotropins | 4 | 2023 | 44 | 1.730 |
Why?
| | Ovulation Induction | 10 | 2026 | 68 | 1.710 |
Why?
| | Oocyte Retrieval | 6 | 2026 | 20 | 1.680 |
Why?
| | Cryopreservation | 5 | 2026 | 115 | 1.650 |
Why?
| | Pregnancy Outcome | 5 | 2024 | 503 | 1.410 |
Why?
| | Infertility | 6 | 2018 | 62 | 1.410 |
Why?
| | Polycystic Ovary Syndrome | 7 | 2026 | 191 | 1.360 |
Why?
| | Ovarian Reserve | 2 | 2023 | 19 | 1.360 |
Why?
| | Estradiol | 7 | 2024 | 517 | 1.360 |
Why?
| | Oocyte Donation | 2 | 2020 | 6 | 1.260 |
Why?
| | Progesterone | 6 | 2024 | 214 | 1.190 |
Why?
| | Reproductive Techniques, Assisted | 4 | 2020 | 48 | 1.160 |
Why?
| | Fertility | 6 | 2019 | 174 | 1.160 |
Why?
| | Pregnancy | 28 | 2026 | 7230 | 1.160 |
Why?
| | Ovary | 6 | 2023 | 236 | 1.150 |
Why?
| | Aromatase Inhibitors | 4 | 2020 | 81 | 1.130 |
Why?
| | Body Mass Index | 14 | 2024 | 2458 | 1.100 |
Why?
| | Anti-Mullerian Hormone | 5 | 2023 | 62 | 1.100 |
Why?
| | Reproduction | 4 | 2026 | 209 | 1.050 |
Why?
| | Menstrual Cycle | 5 | 2019 | 145 | 1.040 |
Why?
| | Sperm Injections, Intracytoplasmic | 5 | 2014 | 15 | 0.960 |
Why?
| | Corpus Luteum | 3 | 2016 | 23 | 0.950 |
Why?
| | Metabolic Syndrome | 5 | 2017 | 364 | 0.940 |
Why?
| | Birth Rate | 3 | 2020 | 32 | 0.920 |
Why?
| | Female | 82 | 2026 | 79499 | 0.910 |
Why?
| | Weight Gain | 4 | 2016 | 562 | 0.850 |
Why?
| | Women's Health | 6 | 2012 | 317 | 0.800 |
Why?
| | Weight Loss | 6 | 2016 | 858 | 0.790 |
Why?
| | Infertility, Male | 5 | 2017 | 69 | 0.790 |
Why?
| | Caloric Restriction | 3 | 2014 | 133 | 0.770 |
Why?
| | Hyperandrogenism | 3 | 2017 | 25 | 0.770 |
Why?
| | Obstetrics | 2 | 2018 | 179 | 0.770 |
Why?
| | Oligomenorrhea | 2 | 2014 | 14 | 0.760 |
Why?
| | Gynecology | 2 | 2018 | 185 | 0.760 |
Why?
| | Adult | 51 | 2026 | 41087 | 0.730 |
Why?
| | Humans | 85 | 2026 | 146342 | 0.690 |
Why?
| | Endometrium | 5 | 2018 | 64 | 0.660 |
Why?
| | Iron | 1 | 2023 | 359 | 0.640 |
Why?
| | Preimplantation Diagnosis | 1 | 2020 | 7 | 0.640 |
Why?
| | Adiposity | 3 | 2015 | 533 | 0.630 |
Why?
| | Body Weight | 3 | 2015 | 968 | 0.630 |
Why?
| | Granulosa Cells | 2 | 2021 | 37 | 0.610 |
Why?
| | Parity | 2 | 2011 | 113 | 0.610 |
Why?
| | Gestational Sac | 1 | 2019 | 1 | 0.590 |
Why?
| | Abortifacient Agents, Nonsteroidal | 1 | 2019 | 20 | 0.580 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 37 | 0.570 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2021 | 1408 | 0.560 |
Why?
| | Pregnancy, Ectopic | 1 | 2019 | 54 | 0.560 |
Why?
| | Injections | 1 | 2019 | 201 | 0.550 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 91 | 0.540 |
Why?
| | Sperm Motility | 2 | 2017 | 34 | 0.540 |
Why?
| | Insulin Resistance | 2 | 2026 | 1247 | 0.540 |
Why?
| | Practice Patterns, Physicians' | 3 | 2018 | 1408 | 0.540 |
Why?
| | Teratozoospermia | 1 | 2017 | 3 | 0.530 |
Why?
| | Premenopause | 2 | 2016 | 130 | 0.530 |
Why?
| | Hormones | 2 | 2017 | 134 | 0.530 |
Why?
| | Methotrexate | 1 | 2019 | 234 | 0.520 |
Why?
| | Reproductive Physiological Phenomena | 1 | 2017 | 2 | 0.510 |
Why?
| | Biometry | 1 | 2017 | 67 | 0.510 |
Why?
| | Fathers | 1 | 2017 | 53 | 0.510 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2017 | 51 | 0.500 |
Why?
| | Ovulation | 6 | 2018 | 46 | 0.490 |
Why?
| | Overweight | 2 | 2013 | 614 | 0.490 |
Why?
| | Premature Birth | 1 | 2020 | 390 | 0.480 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 190 | 0.480 |
Why?
| | Single Embryo Transfer | 1 | 2016 | 3 | 0.480 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 9 | 0.450 |
Why?
| | Retrospective Studies | 14 | 2026 | 17438 | 0.450 |
Why?
| | Ovarian Follicle | 3 | 2021 | 78 | 0.440 |
Why?
| | Coitus | 1 | 2015 | 24 | 0.440 |
Why?
| | Dietary Supplements | 2 | 2019 | 587 | 0.440 |
Why?
| | Evidence-Based Medicine | 3 | 2014 | 731 | 0.440 |
Why?
| | Logistic Models | 8 | 2016 | 2126 | 0.440 |
Why?
| | Insulin | 1 | 2026 | 2525 | 0.440 |
Why?
| | Blastocyst | 3 | 2020 | 50 | 0.420 |
Why?
| | DNA Damage | 1 | 2017 | 439 | 0.420 |
Why?
| | Embryo Implantation | 4 | 2018 | 33 | 0.420 |
Why?
| | Luteal Phase | 5 | 2014 | 51 | 0.420 |
Why?
| | Dietary Fats | 2 | 2016 | 307 | 0.410 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 145 | 0.410 |
Why?
| | Health | 1 | 2014 | 81 | 0.410 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1331 | 0.400 |
Why?
| | Testosterone | 2 | 2016 | 419 | 0.400 |
Why?
| | Gonadotropin-Releasing Hormone | 5 | 2021 | 215 | 0.400 |
Why?
| | Models, Biological | 4 | 2017 | 1761 | 0.390 |
Why?
| | Environmental Exposure | 1 | 2018 | 578 | 0.390 |
Why?
| | Adenomyosis | 1 | 2013 | 7 | 0.390 |
Why?
| | Cancer Survivors | 1 | 2019 | 348 | 0.390 |
Why?
| | Follicle Stimulating Hormone, Human | 2 | 2023 | 14 | 0.380 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 438 | 0.380 |
Why?
| | Longevity | 2 | 2012 | 179 | 0.380 |
Why?
| | Influenza Vaccines | 1 | 2017 | 544 | 0.370 |
Why?
| | Models, Statistical | 1 | 2017 | 669 | 0.370 |
Why?
| | Fasting | 1 | 2014 | 280 | 0.370 |
Why?
| | Young Adult | 17 | 2021 | 14330 | 0.370 |
Why?
| | Diet, Ketogenic | 1 | 2012 | 40 | 0.360 |
Why?
| | Reproductive Medicine | 1 | 2012 | 19 | 0.350 |
Why?
| | Uterus | 1 | 2013 | 227 | 0.350 |
Why?
| | Time Factors | 8 | 2026 | 7109 | 0.350 |
Why?
| | Influenza, Human | 1 | 2017 | 640 | 0.340 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 201 | 0.340 |
Why?
| | Life Expectancy | 1 | 2012 | 72 | 0.340 |
Why?
| | Intra-Abdominal Fat | 1 | 2012 | 104 | 0.340 |
Why?
| | Cytokines | 2 | 2015 | 2081 | 0.320 |
Why?
| | Nutritional Status | 1 | 2013 | 346 | 0.310 |
Why?
| | MicroRNAs | 2 | 2018 | 699 | 0.300 |
Why?
| | Fallopian Tubes | 3 | 2022 | 33 | 0.300 |
Why?
| | Diet | 1 | 2017 | 1273 | 0.300 |
Why?
| | Odds Ratio | 4 | 2016 | 1077 | 0.300 |
Why?
| | Mass Screening | 1 | 2018 | 1307 | 0.300 |
Why?
| | Lithium Chloride | 1 | 2009 | 14 | 0.290 |
Why?
| | Estrogens | 3 | 2019 | 364 | 0.290 |
Why?
| | Vaccination | 1 | 2017 | 1449 | 0.280 |
Why?
| | Fertility Agents, Female | 2 | 2021 | 23 | 0.280 |
Why?
| | Perception | 1 | 2011 | 373 | 0.280 |
Why?
| | Androgens | 3 | 2016 | 179 | 0.280 |
Why?
| | Chorionic Gonadotropin | 1 | 2008 | 77 | 0.270 |
Why?
| | Smoking | 2 | 2015 | 1486 | 0.270 |
Why?
| | Hormone Antagonists | 2 | 2021 | 32 | 0.270 |
Why?
| | Body Composition | 1 | 2012 | 689 | 0.270 |
Why?
| | Urologic Surgical Procedures, Male | 3 | 2014 | 33 | 0.270 |
Why?
| | Societies, Medical | 1 | 2012 | 907 | 0.260 |
Why?
| | Adolescent | 17 | 2021 | 22557 | 0.260 |
Why?
| | Perimenopause | 3 | 2015 | 69 | 0.260 |
Why?
| | Prospective Studies | 9 | 2023 | 8123 | 0.260 |
Why?
| | RNA, Messenger | 1 | 2015 | 2791 | 0.250 |
Why?
| | Markov Chains | 2 | 2017 | 129 | 0.250 |
Why?
| | Monte Carlo Method | 2 | 2017 | 151 | 0.250 |
Why?
| | Hypothalamo-Hypophyseal System | 3 | 2017 | 204 | 0.250 |
Why?
| | Follicular Phase | 3 | 2015 | 41 | 0.240 |
Why?
| | United States | 10 | 2021 | 16136 | 0.230 |
Why?
| | Mitochondria | 1 | 2013 | 997 | 0.230 |
Why?
| | Longitudinal Studies | 6 | 2015 | 3017 | 0.230 |
Why?
| | Cardiovascular Diseases | 3 | 2012 | 2219 | 0.220 |
Why?
| | Biomarkers | 6 | 2021 | 4340 | 0.210 |
Why?
| | Middle Aged | 19 | 2020 | 36619 | 0.210 |
Why?
| | Animals | 15 | 2021 | 38107 | 0.210 |
Why?
| | Pregnancy Complications | 2 | 2024 | 609 | 0.210 |
Why?
| | Infant, Newborn | 3 | 2024 | 6460 | 0.210 |
Why?
| | Nitriles | 3 | 2015 | 212 | 0.210 |
Why?
| | Diet, High-Fat | 2 | 2016 | 267 | 0.200 |
Why?
| | Risk Factors | 9 | 2017 | 10921 | 0.200 |
Why?
| | Triazoles | 3 | 2015 | 190 | 0.200 |
Why?
| | Varicocele | 2 | 2014 | 5 | 0.190 |
Why?
| | Patient Selection | 2 | 2021 | 728 | 0.190 |
Why?
| | Blood Glucose | 2 | 2017 | 2360 | 0.190 |
Why?
| | Computer Simulation | 2 | 2017 | 1014 | 0.190 |
Why?
| | Obesity, Morbid | 1 | 2007 | 287 | 0.180 |
Why?
| | Leiomyoma | 2 | 2017 | 62 | 0.180 |
Why?
| | Epithelial Cells | 1 | 2009 | 1119 | 0.180 |
Why?
| | Uterine Neoplasms | 2 | 2017 | 98 | 0.180 |
Why?
| | Cesarean Section | 1 | 2024 | 230 | 0.180 |
Why?
| | Ultrasonography | 2 | 2018 | 788 | 0.180 |
Why?
| | Cell Nucleolus | 2 | 2012 | 21 | 0.170 |
Why?
| | Hypothalamus | 2 | 2014 | 161 | 0.170 |
Why?
| | Research Subjects | 1 | 2021 | 42 | 0.170 |
Why?
| | Endometriosis | 1 | 2021 | 58 | 0.160 |
Why?
| | Desogestrel | 1 | 2021 | 46 | 0.160 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2022 | 268 | 0.160 |
Why?
| | Pregnancy, Multiple | 1 | 2020 | 19 | 0.160 |
Why?
| | Fertility Preservation | 1 | 2021 | 57 | 0.160 |
Why?
| | Prevalence | 4 | 2012 | 2861 | 0.160 |
Why?
| | Multivariate Analysis | 4 | 2013 | 1543 | 0.160 |
Why?
| | Treatment Outcome | 6 | 2021 | 11821 | 0.150 |
Why?
| | Abortion, Spontaneous | 2 | 2017 | 120 | 0.150 |
Why?
| | Cross-Sectional Studies | 7 | 2018 | 5899 | 0.150 |
Why?
| | Male | 16 | 2018 | 73396 | 0.150 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1942 | 0.140 |
Why?
| | Hysterosalpingography | 1 | 2018 | 9 | 0.140 |
Why?
| | Progestins | 1 | 2019 | 67 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2021 | 1224 | 0.140 |
Why?
| | Bayes Theorem | 2 | 2017 | 426 | 0.140 |
Why?
| | Environmental Health | 1 | 2018 | 42 | 0.130 |
Why?
| | Phthalic Acids | 1 | 2018 | 43 | 0.130 |
Why?
| | Hypogonadism | 2 | 2015 | 89 | 0.130 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 42 | 0.130 |
Why?
| | Puberty | 1 | 2019 | 141 | 0.130 |
Why?
| | Ultrasonography, Interventional | 1 | 2019 | 163 | 0.130 |
Why?
| | Biostatistics | 1 | 2017 | 19 | 0.130 |
Why?
| | Fertility Agents | 1 | 2017 | 3 | 0.130 |
Why?
| | Sweating | 2 | 2014 | 43 | 0.130 |
Why?
| | Insemination, Artificial | 1 | 2017 | 11 | 0.130 |
Why?
| | Genetic Testing | 1 | 2020 | 492 | 0.130 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 71 | 0.120 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 291 | 0.120 |
Why?
| | Likelihood Functions | 1 | 2017 | 138 | 0.120 |
Why?
| | Embryonic Development | 1 | 2017 | 124 | 0.120 |
Why?
| | Aromatase | 2 | 2014 | 37 | 0.120 |
Why?
| | Hypoglycemic Agents | 1 | 2026 | 1412 | 0.120 |
Why?
| | Hot Flashes | 2 | 2014 | 92 | 0.120 |
Why?
| | NF-kappa B | 1 | 2020 | 674 | 0.120 |
Why?
| | Ovarian Diseases | 1 | 2016 | 14 | 0.120 |
Why?
| | Maternal Exposure | 1 | 2018 | 189 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2017 | 162 | 0.120 |
Why?
| | Chronic Disease | 2 | 2014 | 1827 | 0.120 |
Why?
| | Maternal Age | 1 | 2016 | 129 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2018 | 902 | 0.110 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 128 | 0.110 |
Why?
| | Hydrocortisone | 1 | 2017 | 303 | 0.110 |
Why?
| | Clomiphene | 1 | 2015 | 15 | 0.110 |
Why?
| | Incidence | 2 | 2014 | 2936 | 0.110 |
Why?
| | Cumulus Cells | 1 | 2015 | 7 | 0.110 |
Why?
| | Anovulation | 1 | 2015 | 9 | 0.110 |
Why?
| | Transcriptome | 2 | 2021 | 1068 | 0.110 |
Why?
| | Data Interpretation, Statistical | 1 | 2017 | 368 | 0.110 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 110 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2015 | 2502 | 0.110 |
Why?
| | Waist Circumference | 2 | 2017 | 142 | 0.110 |
Why?
| | Circadian Rhythm | 2 | 2017 | 515 | 0.110 |
Why?
| | Obesity, Abdominal | 1 | 2014 | 48 | 0.100 |
Why?
| | Oxidative Stress | 1 | 2021 | 1369 | 0.100 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 278 | 0.100 |
Why?
| | Adiponectin | 1 | 2016 | 243 | 0.100 |
Why?
| | Phospholipids | 1 | 2015 | 215 | 0.100 |
Why?
| | Insurance Coverage | 1 | 2016 | 248 | 0.100 |
Why?
| | Neoplasms | 2 | 2021 | 2954 | 0.100 |
Why?
| | Hysteroscopy | 1 | 2013 | 14 | 0.100 |
Why?
| | Pulsatile Flow | 2 | 2011 | 62 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2015 | 397 | 0.100 |
Why?
| | Reproductive Health | 1 | 2014 | 94 | 0.100 |
Why?
| | Insurance, Health | 1 | 2016 | 318 | 0.090 |
Why?
| | Ketone Bodies | 1 | 2012 | 16 | 0.090 |
Why?
| | Triglycerides | 2 | 2017 | 527 | 0.090 |
Why?
| | Birth Weight | 1 | 2016 | 521 | 0.090 |
Why?
| | DNA Methylation | 1 | 2018 | 725 | 0.090 |
Why?
| | Cohort Studies | 4 | 2012 | 6077 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2012 | 67 | 0.090 |
Why?
| | Fatty Acids | 1 | 2015 | 460 | 0.090 |
Why?
| | Interinstitutional Relations | 1 | 2012 | 56 | 0.090 |
Why?
| | Body Height | 1 | 2013 | 205 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2017 | 3647 | 0.090 |
Why?
| | Education, Continuing | 1 | 2012 | 42 | 0.090 |
Why?
| | Hyperthyroidism | 1 | 2012 | 22 | 0.090 |
Why?
| | Attitude of Health Personnel | 2 | 2018 | 1219 | 0.090 |
Why?
| | Cell Cycle | 1 | 2015 | 595 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2015 | 1792 | 0.080 |
Why?
| | Japan | 1 | 2011 | 149 | 0.080 |
Why?
| | Algorithms | 2 | 2017 | 1849 | 0.080 |
Why?
| | Placenta | 1 | 2018 | 794 | 0.080 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2011 | 43 | 0.080 |
Why?
| | New York | 1 | 2011 | 128 | 0.080 |
Why?
| | China | 1 | 2011 | 280 | 0.080 |
Why?
| | Mice | 4 | 2021 | 18297 | 0.080 |
Why?
| | Glycolysis | 1 | 2012 | 342 | 0.080 |
Why?
| | Congresses as Topic | 1 | 2012 | 226 | 0.080 |
Why?
| | Quality of Life | 2 | 2014 | 3200 | 0.080 |
Why?
| | Body Fat Distribution | 1 | 2010 | 47 | 0.080 |
Why?
| | Research Design | 2 | 2014 | 1143 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 517 | 0.080 |
Why?
| | Ovariectomy | 1 | 2011 | 164 | 0.080 |
Why?
| | Pituitary Gland | 1 | 2011 | 148 | 0.080 |
Why?
| | Abdominal Fat | 1 | 2010 | 51 | 0.080 |
Why?
| | Databases, Factual | 1 | 2016 | 1493 | 0.080 |
Why?
| | Multicenter Studies as Topic | 1 | 2011 | 417 | 0.080 |
Why?
| | Information Dissemination | 1 | 2012 | 226 | 0.080 |
Why?
| | Spermatozoa | 1 | 2010 | 103 | 0.080 |
Why?
| | Acculturation | 1 | 2010 | 55 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2009 | 64 | 0.070 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 74 | 0.070 |
Why?
| | Luteal Cells | 1 | 2008 | 3 | 0.070 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 84 | 0.070 |
Why?
| | Transplantation, Heterologous | 1 | 2009 | 165 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 870 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2011 | 1298 | 0.070 |
Why?
| | Cholesterol | 1 | 2010 | 411 | 0.070 |
Why?
| | Nuclear Pore | 1 | 2008 | 19 | 0.070 |
Why?
| | Postmenopause | 1 | 2010 | 394 | 0.070 |
Why?
| | Bariatric Surgery | 2 | 2009 | 250 | 0.070 |
Why?
| | Siblings | 1 | 2008 | 202 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2012 | 380 | 0.070 |
Why?
| | Epilepsy | 1 | 2012 | 400 | 0.070 |
Why?
| | Patient Compliance | 1 | 2012 | 589 | 0.060 |
Why?
| | Energy Intake | 1 | 2010 | 507 | 0.060 |
Why?
| | Hysterectomy | 1 | 2008 | 139 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4580 | 0.060 |
Why?
| | Signal Transduction | 1 | 2020 | 5246 | 0.060 |
Why?
| | Fever | 1 | 2008 | 322 | 0.060 |
Why?
| | Cuba | 3 | 2010 | 15 | 0.060 |
Why?
| | Central America | 3 | 2010 | 28 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2014 | 1215 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2599 | 0.060 |
Why?
| | South America | 3 | 2010 | 56 | 0.060 |
Why?
| | Puerto Rico | 3 | 2010 | 64 | 0.060 |
Why?
| | Metabolome | 1 | 2009 | 390 | 0.060 |
Why?
| | Metformin | 1 | 2009 | 328 | 0.060 |
Why?
| | Lipids | 1 | 2010 | 714 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2921 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2011 | 1763 | 0.050 |
Why?
| | Hypertension | 2 | 2010 | 1272 | 0.050 |
Why?
| | Diabetes Mellitus | 2 | 2010 | 1101 | 0.050 |
Why?
| | Risk Assessment | 2 | 2011 | 3712 | 0.050 |
Why?
| | Stroke | 1 | 2014 | 1287 | 0.050 |
Why?
| | Energy Metabolism | 1 | 2010 | 930 | 0.050 |
Why?
| | Recovery of Function | 1 | 2008 | 725 | 0.050 |
Why?
| | Inflammation | 1 | 2015 | 2919 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2113 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1503 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2021 | 2070 | 0.040 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2021 | 34 | 0.040 |
Why?
| | Vitrification | 1 | 2021 | 7 | 0.040 |
Why?
| | Ovarian Hyperstimulation Syndrome | 1 | 2021 | 6 | 0.040 |
Why?
| | Oogenesis | 1 | 2021 | 20 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 226 | 0.040 |
Why?
| | Aging | 1 | 2012 | 1996 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2021 | 130 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 678 | 0.040 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2020 | 50 | 0.040 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2020 | 22 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 245 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3926 | 0.040 |
Why?
| | Dominican Republic | 2 | 2010 | 29 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 2020 | 103 | 0.040 |
Why?
| | I-kappa B Proteins | 1 | 2020 | 75 | 0.040 |
Why?
| | Choice Behavior | 1 | 2021 | 179 | 0.040 |
Why?
| | Cell Division | 1 | 2021 | 736 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2021 | 137 | 0.040 |
Why?
| | Child | 1 | 2019 | 22693 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2021 | 487 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 449 | 0.030 |
Why?
| | Exercise | 1 | 2010 | 2213 | 0.030 |
Why?
| | Ovum | 1 | 2018 | 30 | 0.030 |
Why?
| | Sheep, Domestic | 1 | 2017 | 33 | 0.030 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 140 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2018 | 245 | 0.030 |
Why?
| | Pregnancy Tests | 1 | 2017 | 11 | 0.030 |
Why?
| | Hirsutism | 1 | 2017 | 12 | 0.030 |
Why?
| | Phosphorylation | 1 | 2021 | 1724 | 0.030 |
Why?
| | Hypertriglyceridemia | 1 | 2017 | 45 | 0.030 |
Why?
| | Litter Size | 1 | 2016 | 18 | 0.030 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 169 | 0.030 |
Why?
| | Mice, Obese | 1 | 2016 | 68 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 387 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2814 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2008 | 3034 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 189 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 104 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 2012 | 0.030 |
Why?
| | Embryo Disposition | 1 | 2014 | 1 | 0.030 |
Why?
| | Zygote Intrafallopian Transfer | 1 | 2014 | 2 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 94 | 0.030 |
Why?
| | Cleavage Stage, Ovum | 1 | 2014 | 6 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 334 | 0.030 |
Why?
| | Estrone | 1 | 2014 | 41 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 1036 | 0.030 |
Why?
| | Laparoscopy | 1 | 2018 | 487 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2015 | 496 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2016 | 888 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 712 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2021 | 1210 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 752 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 426 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2014 | 541 | 0.020 |
Why?
| | Observer Variation | 1 | 2012 | 356 | 0.020 |
Why?
| | Thyrotropin | 1 | 2012 | 120 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2012 | 97 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1463 | 0.020 |
Why?
| | Sperm Count | 1 | 2010 | 17 | 0.020 |
Why?
| | Vaginal Diseases | 1 | 2010 | 19 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4118 | 0.020 |
Why?
| | Dominica | 1 | 2010 | 3 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3416 | 0.020 |
Why?
| | Surveys and Questionnaires | 2 | 2014 | 6073 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1075 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 790 | 0.020 |
Why?
| | Pregnanediol | 1 | 2008 | 23 | 0.020 |
Why?
| | Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2008 | 7 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3206 | 0.020 |
Why?
| | Papio | 1 | 2008 | 71 | 0.020 |
Why?
| | Survivors | 1 | 2012 | 526 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2010 | 363 | 0.020 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2008 | 68 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 466 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 999 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2008 | 345 | 0.020 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2010 | 198 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3347 | 0.020 |
Why?
| | Cause of Death | 1 | 2009 | 456 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2009 | 615 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2010 | 314 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2009 | 533 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1327 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2016 | 6034 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1998 | 0.010 |
Why?
| | Colorado | 1 | 2013 | 4595 | 0.010 |
Why?
| | Anxiety | 1 | 2010 | 1125 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2010 | 1171 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1512 | 0.010 |
Why?
| | Depression | 1 | 2010 | 1575 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5439 | 0.010 |
Why?
| | Aged | 1 | 2009 | 26432 | 0.000 |
Why?
|
|
Polotsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|